There are other long-term risks associated with Ocrevus and patients with active hepatitis B or are allergic to Ocrevus are not advised to begin the therapy. Other side effects include:
Infections: Ocrevus increases the risk of infections such as respiratory infections, herpes, and skin infections.
Reactivating hepatitis B virus: You should speak to your healthcare team if you’ve had hepatitis B.
Progressive multifocal leukoencephalopathy (PML): Although no patient on the clinical trials for Ocrevus developed this rare brain infection, there is a risk that this could occur.
A weakened immune system: If Ocrevus is taken with other multiple sclerosis medications it may lead to a weakened immune system and leave patients more susceptible to infections.
Cancer: Ocrevus may increase your risk of developing certain types of cancer, including breast cancer. You will need to ensure you have regular cancer screenings.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.